Obese Clinical Trials

19 recruiting

Obese Trials at a Glance

70 actively recruiting trials for obese are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Not Applicable with 32 trials, with the heaviest enrollment activity in Dallas, Miami, and San Antonio. Lead sponsors running obese studies include BrightGene Bio-Medical Technology Co., Ltd., Hanmi Pharmaceutical Company Limited, and University of Avignon.

Treatments under study

About Obese Clinical Trials

Looking for clinical trials for Obese? There are currently 19 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Obese trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Obese clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 70 trials

Recruiting
Not Applicable

Study of the Effect of Capsinoid Supplementation on Brown Adipose Tissue in Obese Adolescents

ExerciseObese AdolescentsDiet Modification+1 more
University of Avignon38 enrolled1 locationNCT06916208
Recruiting
Not Applicable

Stable Isotopes- Adults With Obesity

Obese Patients (BMI ≥ 30 kg/m²)
University of Illinois at Urbana-Champaign8 enrolled1 locationNCT07020741
Recruiting
Phase 1

A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults

HealthyOverweight and Obese Adults
Syntis Bio64 enrolled1 locationNCT07307274
Recruiting
Phase 1Phase 2

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Type 2 Diabetes Mellitus (T2DM)Obese or Overweight Healthy Volunteers
Alnylam Pharmaceuticals144 enrolled20 locationsNCT06845202
Recruiting
Phase 1

A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese

OverweightObese
Novo Nordisk A/S100 enrolled1 locationNCT07411560
Recruiting
Phase 1

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

Obese But Otherwise Healthy Participants
Corbus Pharmaceuticals Inc.252 enrolled15 locationsNCT07310901
Recruiting
Not Applicable

Comparison of Airway Ultrasonography and Laryngoscopy Methods in Obese Patients

Correlation of Difficult Airway Markers With Ultrasonographic Measurements in Obese Patients
Trabzon Kanuni Education and Research Hospital180 enrolled1 locationNCT07482436
Recruiting
Not Applicable

The Metabolic Effects of Oral Tributyrin Administration

Healthy Overweight/Obese
University of Aarhus12 enrolled1 locationNCT07463495
Recruiting
Not Applicable

Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients

Esophageal CancerGastric CancerHypoxemia+1 more
Zhejiang University410 enrolled5 locationsNCT07175155
Recruiting
Not Applicable

Fructose Intestinal Gluconeogenesis

Healthy ParticipantsObese But Otherwise Healthy Participants
Touro University, California40 enrolled1 locationNCT07209202
Recruiting
Not Applicable

Trans-nasal Endoscopy for Bariatric Patients

ObesityGastrointestinal DiseasesObese+2 more
Christopher C. Thompson, MD, MSc100 enrolled1 locationNCT06200961
Recruiting
Phase 1

A Single Ascending Dose Study of HM17321 in Healthy Adult Participants

ObesityObese
Hanmi Pharmaceutical Company Limited40 enrolled1 locationNCT07219589
Recruiting
Not Applicable

Time-Restricted Eating for Weight-Loss Maintenance

Overweight or Obese Adults
Harbin Medical University500 enrolled10 locationsNCT07163455
Recruiting
Not Applicable

NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status

MDDObese Adults
National Science and Technology Council, Taiwan50 enrolled1 locationNCT07439744
Recruiting
Phase 1Phase 2

Pilot Testing a Novel Approach to Pediatric Obesity Treatment

Obese AdolescentsOverweight Adolescents
Texas Tech University30 enrolled1 locationNCT06755827
Recruiting
Phase 1

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes
Alveus Therapeutics, Inc.180 enrolled1 locationNCT07399678
Recruiting
Phase 2

Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

ObesityWeight LossObese+1 more
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics50 enrolled17 locationsNCT07400588
Recruiting
Not Applicable

KETO-TUMOR: a Study on Brain Tumors and Central Obesity

Obese PatientsHypothalamic Neoplasms
Meyer Children's Hospital IRCCS30 enrolled1 locationNCT07396896
Recruiting
Phase 1

A Study of XW003 Injection in Chinese Adolescents With Obesity

ObesityObese Adolescents
Hangzhou Sciwind Biosciences Co., Ltd.48 enrolled1 locationNCT07143227
Recruiting
Phase 2

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

ObesityOverweightOverweight and Obesity+2 more
Memorial Sloan Kettering Cancer Center1,785 enrolled1 locationNCT05770570